Loading...
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
As biologic, epidemiologic, and clinical trial data have demonstrated, inflammation is a key driver of atherosclerosis. Circulating biomarkers of inflammation, including high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6), are associated with increased risk of cardiovascular events...
Na minha lista:
| Udgivet i: | Front Cardiovasc Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6403155/ https://ncbi.nlm.nih.gov/pubmed/30873416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00016 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|